Skip to content
Farcast Biosciences logo — 24,000 human tumors and counting - building the most precise...

Farcast Biosciences

24,000 human tumors and counting - building the most precise functional precision tumor microdynamics platform

Founded 2019 India Bengaluru, India 38 employees Pre-Seed Total: $74.63M Biotechnology, Health Care +1

General Information

Company Name Farcast Biosciences
Founded Year 2019
Location India Bengaluru, India
Employees 38
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with Farcast Biosciences. To contact Farcast Biosciences, visit farcastbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Farcast Biosciences compare?

A PDF of Farcast Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Farcast Biosciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Farcast Biosciences

Farcast Biosciences is a biotechnology startup that has been dedicated to building the most precise functional precision tumor microdynamics platform since its founding in 2010. Their slogan "24,000 human tumors and counting" reflects their commitment to accumulating a substantial dataset for comprehensive analysis. Farcast utilizes data from live human tumors to predict clinical response, with the ultimate goal of providing accurate insights into every patient tumor, every time. Their platform aims to contribute to improved outcomes for cancer patients in the Health Care and Pharmaceutical industries. Techstars' $120.00K Pre Seed Round investment in Farcast Biosciences in 15 July 2019 underscores the confidence of renowned investors in the potential of this India-based startup.

Business keywords: tumor microdynamics platform, clinical diagnostics, cancer treatment, oncology, translational biology, preclinical drug testing, oncolytic virus, immuno-oncology, monoclonal antibodies, bispecifics, tumor microenvironment, biopharmaceutical research

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round $120.00K 1
Techstars
15 Jul 2019
Series C $40.00M 5
RA Capital Management, Sands Capital Ventures +3
12 Jul 2018
Series B $27.40M 4
RA Capital Management, Tata Capital +2
29 Aug 2016
Series B $4.91M 1
Tata Capital
24 Oct 2013
Grant Undisclosed -
01 Jan 2012
Series A $2.20M 2
Tata Capital, Karnataka Information Technology Venture Capital Fund
28 Apr 2010

Farcast Biosciences Alternatives & Competitors

View All Alternatives
Farcast Biosciences vs
VitroScan
VitroScan The Netherlands

Predictive Testing Solutions

Grant
10 employees
Biopharma, Biotechnology
Farcast Biosciences vs

#lifeunderthesurface #BBJBestPlacesToWork2023,2022,2021 #BostonGlobeTopPlacesToWork2023,2022,2021

Post-IPO Equity
14 employees
Biotechnology, Health Care
Farcast Biosciences vs
TME Pharma
TME Pharma Germany

Developing novel therapies for treatment of the most aggressive cancers by acting on the tumor micro...

Post-IPO Equity
12 employees
Biotechnology, Health Care

FAQ About Farcast Biosciences

24,000 human tumors and counting - building the most precise functional precision tumor microdynamics platform
Farcast Biosciences was founded in 2019.
Farcast Biosciences is headquartered in Bengaluru, India.
Farcast Biosciences operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on tumor microdynamics platform, clinical diagnostics, cancer treatment and oncology.
Farcast Biosciences has approximately 38 employees.
Farcast Biosciences has completed 6 funding rounds, raising a total of $74.63M. The latest funding stage is Pre-Seed.
Top alternatives and competitors to Farcast Biosciences include VitroScan, Surface Oncology Inc., TME Pharma, Vortex Biosciences, OncXerna Therapeutics . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Farcast Biosciences and VitroScan are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Farcast Biosciences, https://bouncewatch.com/company/farcast-biosciences, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout